International Society for Extracellular Vesicles (ISEV) 2013 ConferenceWednesday, April 17Massachusetts General Hospital
In recent years, there has been an explosion of interest and research activity and translational clinical activity involving extracellular vesicles (EMVs) biology. The EMVs represent a biological phenomenon with vast implications for the diagnosis and therapy and understanding of human diseases. For example, in cancer, EMVs are understood as mediators of intercellular communication that influences cell growth, tumor invasion, drug resistance, and immune evasion. EVs have been implicated to spread prions and toxic proteins into the nervous system of patients with neurodegenerative diseases, including transmissible spongiform encephalopathies, Alzheimer’s disease, Parkinson’s disease, tauopathies, and amyotrophic lateral sclerosis. In virology, herpes simplex virus type 1, Epstein-Barr virus, and human immunodeficiency virus have been found to use EVs to promote infection and avoid immune rejection by the host. We anticipate each day commencing with a 3-4 hour keynote session including an educational symposium as well as key note presentations by thought leaders within thematic areas. Thereafter 2-4 parallel sessions will be ongoing reflecting highly specific areas of research. Concomitant with keynote and specific sessions, posters will be available for review as virtual posters and poster boards. Each late afternoon will include a chair-lead walk through of similarly themed posters. Registration is required. For more information and to register, please visit www.isevmeeting.org Recent Activity |
||